Squarepoint Ops LLC Humanigen, Inc Transaction History

Squarepoint Ops LLC

  • $99.2 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.81 - $3.97 $302,688 - $663,907
-167,231 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.66 - $8.22 $339,161 - $761,722
92,667 Added 124.28%
167,231 $622,000
Q3 2021

Nov 15, 2021
BUY
$5.93 - $17.83 $442,164 - $1.33 Million
74,564 New
74,564 $442,000

Others Institutions Holding HGEN

# of Institutions
3
Shares Held
541K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email